Narcolepsy is a serious and life-altering condition that can disrupt nearly every aspect of daily life. It is often associated with debilitating symptoms such as excessive daytime sleepiness, sudden muscle weakness (cataplexy), hallucinations, and sleep paralysis. If left untreated, narcolepsy can significantly impact a person’s quality of life, affecting work, education, relationships, and overall well-being.

Advances in the molecular understanding of narcolepsy have paved the way for more targeted therapies. These treatments go beyond symptom management, focusing on the neurological pathways and chemical imbalances, such as the loss of hypocretin (orexin), that drive the condition. By addressing these root causes, targeted therapies aim to improve sleep regulation and enhance patients’ daily functioning and quality of life.

At iNGENū, our team of researchers and clinicians is dedicated to advancing narcolepsy research. Through innovative trial designs and a patient-centered approach, we work to accelerate the development of new treatments that offer effective and sustainable solutions for individuals living with narcolepsy.